JOSE MANUEL
VALDIVIELSO REVILLA
CON
Universitat Autònoma de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat Autònoma de Barcelona (7)
2024
-
Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus
International Journal of Molecular Sciences, Vol. 25, Núm. 5
2023
2021
-
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
BMC Nephrology, Vol. 22, Núm. 1
-
Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations
HIV Medicine, Vol. 22, Núm. 7, pp. 581-591
-
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease
Aging, Vol. 13, Núm. 19, pp. 22690-22709
2019
-
Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
Cardiovascular Diabetology, Vol. 18, Núm. 1
2018
-
Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes
Atherosclerosis, Vol. 276, pp. 50-57